Why did FMC report a significantly larger net loss in Q1 2026 compared to Q1 2025, and what were the primary drivers behind its adjusted EPS beat despite the loss?

FMC reported a first-quarter net loss of $281.2 million, sharply up from a $15.6 million loss in the prior-year quarter, driven by a mid-single-digit decline in average prices, tariffs, and high manufacturing costs. Although adjusted EPS swung from a gain of $0.18 in 2025 to a loss of $0.23 in 2026, it still beat analysts’ consensus by 39.5% — indicating that while the company’s underlying profitability deteriorated substantially, its performance was less bad than expected, likely due to cost containment or one-time adjustments not detailed in the text.

How does FMC’s Q2 2026 sales and adjusted EPS guidance compare to analyst expectations, and what specific factors does the company cite for the shortfall?

FMC’s Q2 2026 sales guidance of $850 million–$900 million is 17% lower year over year at the midpoint, falling well short of the $978.1 million consensus estimate; adjusted EPS is forecast at $0.16–$0.26, representing a 70% year-over-year decline and missing the $0.46 consensus. The company attributes the shortfall to lower prices, lower volumes in diamide products, and the sale of its commercial business in India.

FMC Beats Estimates, But Q2 Guidance Falls Short of Consensus

Apr 30, 2026

FMC Corp. reported a Q1 net loss and revenue decline due to pricing pressures, yet adjusted EPS exceeded expectations. Strategic options including a potential sale are under review amidst challenging agrochemical market conditions.

chemweek

2026-04-30

FMC Beats Estimates, But Q2 Guidance Falls Short of Consensus

2026-06-24

FMC reaches deal to sell Delaware property for $114M

2026-07-07

Tessenderlo to Acquire 20% Stake in FMC

2026-09-26

Tessenderlo Closes $403 Million Investment in FMC

FMC Beats Estimates, But Q2 Guidance Falls Short of Consensus

FAQ